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White matter (WM) neuroimaging studies have shown varied findings at different stages of schizophrenia (SZ). Understanding
these variations may elucidate distinct markers of genetic vulnerability and conversion to psychosis. To examine the similarities
and differences in WM connectivity between those at-risk for and in early stages of SZ, a cross-sectional diffusion tensor imaging
study of 48 individuals diagnosed with first-episode SZ (FE-SZ), 37 nonpsychotic individuals at a high genetic risk of SZ (GHRSZ), and 67 healthy controls (HC) was conducted. Decreased fractional anisotropy (FA) in the corpus callosum (CC), anterior
cingulum (AC), and uncinate fasciculus (UF) was observed in both the GHR-SZ and FE-SZ groups, while decreased FAs in the
superior longitudinal fasciculus (SLF) and the fornix were only seen in the FE-SZ participants. Additionally, both GHR-SZ and FESZ showed worse executive performance than HC. The left SLF III FA was significantly positively correlated with hallucinations,
and right SLF II was positively correlated with thought disorder. The presence of shared WM deficits in both FE-SZ and GHR-SZ
individuals may reflect the genetic liability to SZ, while the disparate FA changes in the FE-SZ group may represent symptomgenerating circuitry that mediates perceptual and cognitive disturbances of SZ and ultimately culminates in the onset of psychotic
episodes.

1. Introduction
Disconnectivity of different brain regions, which is putatively
mediated by white matter (WM) abnormalities, is widely
considered to be a key feature of schizophrenia (SZ) [1–
3]. Postmortem histological studies support the involvement
of WM abnormalities in the pathophysiology of SZ [4,
5]. Decreased expressions of myelin/oligodendrocyte-related
genes have been reported in SZ studies [6, 7]. Structural
MRI studies have also implicated WM abnormalities in SZ,
demonstrating altered WM volumes in multiple lobes of SZ
patients [8–10]. Similar WM volumetric changes have been

observed in SZ patients experiencing their first psychotic
episode (FE-SZ) and in nonpsychotic healthy populations
who are at increased genetic high-risk for SZ (GHR-SZ) [11–
13]. Recently, diffusion tensor imaging (DTI) has further
substantiated WM involvement in SZ. In chronic SZ, DTI
studies have detected widespread abnormalities in the WM
integrity. The WM bundles that have been most frequently
observed to be affected in SZ include the corpus callosum
(CC), anterior cingulum (AC), uncinate fasciculus (UF),
fornix (FX), and superior longitudinal fasciculus (SLF) [14–
18]. Despite common WM abnormalities across the stages
of SZ, findings from FE-SZ and GHR-SZ populations have
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demonstrated patterns of WM abnormalities that are distinct
from those observed in chronic SZ [1, 19–21].
Longitudinal studies have observed deviations in cognition, emotion, and behavior in individuals with SZ years
before illness onset [22], implicating altered neurodevelopment in individuals with SZ. Consequently, it is likely
that disconnectivity among brain regions long predates the
symptomatic onset of SZ. Genetic factors appear to contribute
significantly to the altered neurodevelopment observed in
SZ. Previous observations on first-degree relatives of the
SZ patients, including siblings, parents, and monozygotic
twin pairs, as well as the offsprings, raised the possibility
of identifying endophenotypes of this disease by comparing
with HC and SZ [13, 23–26]. Altered WM in SZ’s first relatives
was reported in frontal lobe [27, 28], hippocampus [28],
cingulum angular area [20], anterior limb of the internal
capsule [29], areas close to the right middle and superior
frontal gyri [20], forceps minor, and SLF [30]. However, these
findings were inconclusive because of heterogonous samples,
such as the samples with wide age range or chronic illness
duration.
Among the first-degree relatives, the offsprings’ prevalence is higher than normal people [31], meaning that they are
at increased risk for developing SZ in their later life, so they
constitute an important high-risk group to probe markers
of genetic vulnerability to SZ. However, such markers alone
are not sufficient to identify those at the greatest risk for
conversion to SZ. The FE-SZ group, compared with chronic
SZ, has the advantages that they are in the very early stages of
SZ and are free of confounding influence by multiple relapse,
long illness duration, and psychotropic medications. FE-SZ
individuals represent the transition period from genetic vulnerability to chronic psychotic illness. Comparisons of FE-SZ
and GHR-SZ individuals may provide important insight into
the brain abnormalities that transform genetic vulnerability
to clinical manifestation and disease progression in SZ.
In this study, we examined WM fractional anisotropy
(FA) in FE-SZ, GHR-SZ, and healthy control (HC) participants using a voxel-based DTI approach. We opted to
apply a voxel-based analysis because it has been shown
to be more sensitive to subtle WM differences than other
approaches such as tract-based and ROI-based analysis [1].
Furthermore, voxel-based analysis has shown strong correspondence with other analyses in localizing regional WM
abnormalities in the studies of chronic SZ [1, 32]. Given the
paucity of definitive evidence, it is difficult to hypothesize
the specific fiber bundles involved across the different stages
of SZ. However, we theorize that shared versus distinct WM
abnormalities between GHR-SZ and FE-SZ point to markers
of genetic susceptibility and neuropathological processes in
SZ, respectively: (1) WM alterations shared between FESZ and GHR-SZ, when compared to HC, reflect genetic
vulnerability; (2) distinct WM alterations observed only
in FE-SZ, when compared to GHR-SZ and HC, represent
symptom-generating processes.

2. Methods
2.1. Subjects. Forty-eight FE-SZ, 37 GHR-SZ, and 67 HC
individuals took part in the study. FE-SZ and GHR-SZ
participants were recruited at the outpatient clinic of the

BioMed Research International
Department of Psychiatry, First Affiliated Hospital of China
Medical University, Shenyang, China. HC participants were
recruited from local community via advertisements. The
study was approved by the Institutional Review Board of
China Medical University. All participants provided written
informed consent.
Absence or presence of Axis I and Axis II disorders was
confirmed by consensus between two trained psychiatrists
using the Structured Clinical Interview for DSM-IV (SCID)
[33] or the K-SADS-PL [34] for participants under age 18.
Individuals were excluded from the study for any history of
substance/alcohol abuse or dependence, neurological disorder, head injury, concomitant major medical disorder that
may affect brain microstructure, or contraindications for
MRI.
The FE-SZ participants met DSM-IV criteria for
schizophrenia, schizophreniform disorder, or schizoaffective
disorder without any other Axis I disorders. All FE-SZ
participants were in their first psychotic episode with illness
duration of less than one year. With regard to medication
status, 24 of the FE-SZ participants were antipsychotic-naı̈ve,
while the other 24 participants were taking antipsychotic
medications. The GHR-SZ participants had one parent with
SZ and did not meet criteria for any DSM-IV Axis I disorders.
The HC participants were selected to match in age and sex the
FE-SZ and GHR-SZ participants. They had no personal or
familial history of Axis I psychiatric disorders. Detailed
demographic and clinical characteristics are presented in
Table 1.
2.2. Imaging Acquisition and Processing. All participants were
scanned using a GE Signa HDX 3.0T magnetic resonance
imaging scanner with a standard 12-channel head coil at The
First Affiliated Hospital of China Medical University. Head
motion was minimized with foam padding. Diffusionweighted images were acquired using a spin-echo planar
imaging sequence parallel to the anterior-posterior commissure plane with the following parameters: TR = 17000 ms,
TE = 85.4 ms, image matrix = 120 × 120, field of view =
240 × 240 mm2 , 65 contiguous slices of 2 mm without gap,
25 noncollinear directions, and one no diffusion-weighting
baseline image.
Image preprocessing was performed using PANDA
(http://www.nitrc.org/projects/panda), a fully automated program for processing of brain diffusion images. After motion
and eddy current correction were performed, individual FA
images of native space were registered to the FA template
in MNI (Montreal Neurological Institute) space, followed by
resampling the images to a customized spatial resolution 1 ×
1 × 1 mm with subsequent warping transformations. Lastly,
the FA images were smoothed by a 6 mm Gaussian kernel to
reduce noise and misalignment. The resulting images were
then used in statistical analyses.
2.3. Statistical Analyses. Voxel-based analysis of FA for all
WM voxel was performed using analysis of covariance
(ANCOVA) in second-level analysis in SPM8 (http://www.fil
.ion.ucl.ac.uk/spm) with diagnostic group as an independent
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Table 1: Demographic and clinical data of participants.

Age (year, mean ± SD)
Sex (F/M)
Handedness (R/L/MIX)
Medication (yes/no)
Illness duration (month, mean ± SD)
BPRS (mean ± SD)
BPRS (subscore_anxiety/depression)
BPRS (subscore_Lack of energy)
BPRS (subscore_Thought disorder)
BPRS (subscore_activition)
BPRS (subscore_Hostility/suspicion)
Wisconsin_Total Correct
Wisconsin_Categories Completed
Wisconsin_Total Errors
Wisconsin_Perseverative Error
Wisconsin_Nonperseverative Errors

FE-SZ (𝑛 = 48)
19.6 ± 4.21
22/26
44/1/3
24/24
5.16 ± 9.20
38.47 ± 13.39ab
8.09 ± 4.16ab
8.51 ± 4.37ab
10.14 ± 4.56ab
4.70 ± 2.03ab
7.49 ± 3.75ab
18.58 ± 12.19a
1.65 ± 1.77a
29.42 ± 12.19a
11.96 ± 12.07
17.46 ± 7.40a

GHR-SZ (𝑛 = 37)
19.97 ± 5.36
23/14
33/1/3
1/36
N/A
18.65 ± 1.51
4.57 ± 1.35
4.00 ± 0.00
4.00 ± 0.00
3.00 ± 0.00
3.05 ± 0.33
22.31 ± 12.89c
2.63 ± 2.24c
25.69 ± 12.89c
11.66 ± 13.13
14.03 ± 8.45c

HC (𝑛 = 67)
21.07 ± 4.84
35/32
64/0/3
N/A
N/A
18.01 ± 0.122
4.00 ± 0.00
4.00 ± 0.00
4.00 ± 0.00
3.01 ± 0.121
3.00 ± 0.00
32.49 ± 11.59
4.34 ± 1.96
15.51 ± 11.59
6.26 ± 7.57
9.26 ± 4.59

𝑝
𝑝 = 0.234
𝑝 = 0.326
<0.609

<0.000
<0.000
<0.000
<0.000
<0.000
<0.000
<0.000
<0.000
<0.000
0.069
<0.000

SD: standard deviation.
BPRS: Brief Psychiatric Rating Scale.
FE-SZ: first-episode schizophrenia patients.
GHR-SZ: individuals at genetic high risk for schizophrenia.
HC: healthy controls.
a
FE-SZ significantly different from HC, 𝑝 < 0.05. b FE-SZ significantly different from GHR-SZ, 𝑝 < 0.05. c GHR-SZ significantly different from HC, 𝑝 < 0.05.

factor and age and sex as covariates. Statistical significance
was defined by corrected 𝑝 < 0.05 with thresholds at uncorrected 𝑝 < 0.01 and cluster size > 109 voxels as determined
by Monte Carlo simulation in AlphaSim [35].
For clusters showing significant differences, FA values
were extracted and used in post hoc comparisons. Twosample 𝑡-tests of each significant cluster were performed to
determine the relative direction of differences between
groups (FE-SZ versus HC, GHR-SZ versus HC, and FE-SZ
versus GHR-SZ), after controlling for age and sex. Statistical
significance was defined by 𝑝 < 0.015 (0.05/3) to achieve
Bonferroni correction. The effect of medications was further
assessed by comparing nonmedicated versus medicated FESZ participants, as well as using the medication as the
additional covariate in additional analyses of extracted FAs.
The psychotic symptoms and executive performance were
assessed with Brief Psychiatric Rating Scale (BPRS) and Wisconsin card sorting test (WCST). The Pearson’s correlation
analyses were performed between the FA values showing
significant differences among three groups and BPRS (total
scores and factor scores) as well as WCST performance.

3. Results
Significant effect of diagnostic group was observed in 3
clusters: (1) the anterior/posterior genu and body of CC and
AC, (2) the right SLF II [SLF subcomponents were defined as
four subdivisions in Makris’ study [36]], and (3) the left SLF
III (MNI coordinates for the point of maximal association,
resp.: 𝑥 = 4 mm, 𝑦 = 32 mm, 𝑧 = 8 mm, 458 voxels, and
𝑇 = 4.01; 𝑥 = 34 mm, 𝑦 = 26 mm, 𝑧 = 18 mm, 169 voxels,

and 𝑇 = 3.95; 𝑥 = −44 mm, 𝑦 = −24 mm, 𝑧 = 26 mm,
110 voxels, and 𝑇 = 3.75; 𝑝 < 0.05 AlphaSim corrected)
(Figure 1). Group differences were also observed in clusters
within the FX and UF, although the cluster sizes were smaller
than the predetermined threshold (MNI coordinates for the
point of maximal association, resp.: 𝑥 = 0 mm, 𝑦 = −2 mm,
𝑧 = 4 mm, 96 voxels, and 𝑇 = 3.67; 𝑥 = −24 mm, 𝑦 = 18 mm,
𝑧 = −14 mm, 47 voxels, and 𝑇 = 3.56; 𝑝 < 0.01, uncorrected).
Post hoc analyses revealed decreased FA in the CC, AC,
and UF in both the FE-SZ and GHR-SZ group when compared to the HC group, with no significant difference in FA
between FE-SZ and GHR-SZ participants (Figure 2). Significant decrease in FA was found in the right SLF II, left SLF
III, and FX in the FE-SZ participants, but not in GHR-SZ
participants, when compared to HC (Figure 2).
FAs did not differ significantly between nonmedicated
and medicated FE-SZ participants in any WM cluster identified in ANCOVA, indicating no confounding effect from
medications. Additionally, when the medication was used as
additional covariate, the same results were obtained except
CC. Decreased FAs were shown only in GHR-SZ, but not in
FE-SZ, when compared to HC.
All the subjects except 5 FE-SZ patients finished the BPRS
assessment. 26 FE-SZ, 32 GHR-SZ, and 35 HC finished the
WCST (Table 1). We found significant differences among the
three groups on BPRS and WCST (except the perseverative
errors, 𝑝 = 0.069). Post hoc analyses showed that the
BPRS scores were significantly higher in FE-SZ compared to
GHR-SZ and HC, but not between GHR-SZ and HC. WCST
performance in FE-SZ subjects was worse than GHR-SZ and
HC, but no differences existed between GHR-SZ and HC.

4
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Figure 1: White matter clusters identified in the analysis of covariance (ANCOVA). Images display the white matter bundles yielded from
ANCOVA. Fractional anisotropy differs in the (a) right superior longitudinal fasciculus II, 𝑥 = 34 mm, (b) corpus callosum and anterior
cingulum, 𝑥 = 8 mm, (c) fornix as well as corpus callosum/anterior cingulum, 𝑥 = 4 mm, (d) left superior longitudinal fasciculus III,
𝑥 = −44 mm, and (e) left uncinate fasciculus, 𝑧 = −14 mm, among the healthy control, genetic high-risk, and first-episode schizophrenia
participants.

Pearson’s correlation analyses were performed between
the BPRS scores and FA value of left SLF III, right SLF II,
and fornix in FE-SZ. The left SLF III FA was significantly
positively correlated with hallucinations score of BPRS (𝑟 =
0.309, 𝑝 = 0.044), and right SLF II was positively correlated
with thought disorder subscore (𝑟 = 0.293, 𝑝 = 0.057). The
Pearson’s correlation analyses between WCST performance
and the FA values of the CC, AC, and UF did not show
significant associations.

4. Discussion
In this study, we performed a voxel-based DTI analysis to
investigate the similarities and differences in WM integrity
between the FE-SZ and GHR-SZ participants. We found
decreased FA in the CC, AC, and UF in both the FE-SZ
and GHR-SZ groups when compared to the HC group, while
decreased FA in the right SLF II, left SLF III, and FX was
only evident in the FE-SZ group. These findings demonstrate
partially overlapped and clearly distinct alterations in WM
integrity between FE-SZ and GHR-SZ individuals.
The findings herein agree well with general findings from
other DTI studies of disrupted intra- and interhemispheric
structural WM connections in SZ. They provide further
evidence for the conceptualization of SZ as a disconnectivity
syndrome. We observed widespread FA deficits in SZ in
WM bundles that connect hetero modal association cortices
(HASC), such as the inferior parietal lobule, ventral prefrontal cortex, and superior temporal gyrus. The HASC serve

as convergence points for multimodal sensory inputs and
organize these inputs to guide responses to environmental
stimuli and demands [2]. The dynamics between the HASC
ultimately forms an internal abstraction of the external world
and mediates adaptation to the external environment, online
monitoring of feedback, and interactions between oneself
and the environmental context. WM deficits, similar to
those found in this study, would likely result in disturbed
functional coordination among the HASC, which is a longheld conceptualization of SZ pathophysiology [2, 37]. The
subsequent disruption in the orchestration of HASC function
could lead to a myriad of cognitive, emotional, and behavioral
impairments, as seen in SZ [38, 39].
Decreased FAs in the CC, AC, and UF were observed
in both the FE-SZ and GHR-SZ groups, relative to the HC
group. Findings of abnormalities in the CC have been fairly
consistent across the different stages of SZ [3, 40–43]. In the
at-risk populations, a similar voxel-based study found most
pronounced changes in the body and splenium of CC in
FE-SZ individuals with more modest alterations in at-risk
individuals [44]. Other studies have observed abnormalities
in the genu of the CC in FE-SZ using region of interest (ROI)
and tract-based approaches [41, 45], as well as an association
between decreased FA in the CC genu and illness duration in
chronic SZ.
Shared WM deficits were also found in the frontotemporal (e.g., the UF) and frontolimbic (e.g., the AC) pathways
in the FE-SZ and GHR-SZ groups. Skewed distribution of
FA in the left UF has been previously reported in studies
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Figure 2: Comparisons of fractional anisotropy (FA) value for white matter clusters of ANCOVA group differences. Shown here are the mean
(±standard deviation) FA values extracted from each cluster labeled by the name of white matter bundle and resulting group differences among
the first-episode schizophrenia patients (FE-SZ), genetic high-risk individuals (GHR-SZ), and healthy control participants (HC, ∗ 𝑝 < 0.05,
corrected by Bonferroni correction).

of FE-SZ, implicating abnormalities at the center of the UF.
Correlation between FA in the UF and negative symptoms,
as well as an accelerated decline in UF FA with aging,
has been shown in chronic SZ [46]. In our earlier work
using a ROI-based approach, we found decreased FA and
diminished left-greater-than-right asymmetry in the AC in
chronic SZ [14, 15]. The AC connects the anterior cingulate
cortex (ACC) with prefrontal limbic regions, the amygdala,
and the thalamus [5]. Previous studies have revealed reduced
glial cells, cortical thinning, and smaller volume in the ACC

of SZ patients [5, 47, 48]. In conjunction with prior evidence,
the current findings suggest that disturbances in the CC, AC,
and UF indicate genetic susceptibility to SZ and are present
before the manifestation of psychosis and persist as the illness
progresses.
Distinct from the GHR-SZ group, the FE-SZ group
showed additional WM alterations in the right SLF II, left
SLF III, and FX, when compared to the HC group. The
SLF II and SLF III play overlapping roles in integrating
information in the frontoparietotemporal circuitry [36, 49],
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particularly in auditory perception and speech production.
The SLF III originates from rostral inferior parietal lobule
and projects to Broca’s area, and the SLF II (including the
rostral arcuate fasciculus) relays communication between
Broca’s, Geschwind’s, and Wernicke’s regions [36]. Hallucination severity has been associated with altered FA in the
SLF in SZ, suggesting that the SLF is a neural substrate for
auditory hallucination in SZ [46]. The FX carries connections
between the hippocampus and hypothalamus. Several lines
of evidence have indicated the involvement of hippocampus
and FX in SZ pathophysiology. Decreased FA in the FX
has been shown in conjunction with bilateral hippocampal
volume loss in SZ [50]. Decreased FA in the FX has also
been found in chronic SZ along with decreased restingstate functional connectivity between the hippocampus and
brain regions subserving episodic memory, including the
prefrontal cortex and posterior cingulate cortex [18]. As they
were only seen in the symptomatic FE-SZ group and not in
the vulnerable GHR-SZ group, we postulate that the findings
of FA reductions in the SLF and FX represent symptomgenerating WM abnormalities in SZ.
Our findings of shared and distinct abnormalities of WM
integrity in FE-SZ and GHR-SZ raise intriguing questions
about the role of genetic, neural, and other factors in
conversion to psychosis among individuals at-risk for SZ.
Are there differential markers for vulnerability to SZ versus
definite progression to psychosis? Are certain factors more
critical in conversion to psychosis? Our findings appear to
suggest that disruptions in the CC, AC, and UF, shared
by the FE-SZ and GHR-SZ groups, may represent genetic
vulnerability to SZ, but do not result in symptomatic onset
of SZ, whereas abnormalities in the right SLF II, left SLF
III, and FX, found only in the FE-SZ group, may reflect
key neural processes that generate definitive symptoms of
SZ. In addition, our findings in the SLF and FX in FESZ may represent symptom-generating processes that are
present in all psychotic disorders. Studies of these regions
in other types of psychosis could provide insight into the
level of neural differentiation among psychotic disorders. Our
findings also speak to the synergistic effects of susceptibility
and illness-generating factors in psychotic conversion of atrisk individuals. Longitudinal studies have shown higher
rates of conversion to psychosis when genetic predisposition
was coupled with environmental adversities [51]. Conceivably, individuals at-risk for SZ may develop psychosis as a
result of dysfunction within key symptom-generating neural
circuitry due to further WM disruptions from environmental
factors, such as repeated exposure to psychosocial stress, in
conjunction with predisposing neural vulnerabilities.
The inclusion of both FE-SZ and GHR-SZ individuals is
the major strength of our study. This allows us to dissociate
WM abnormalities related to genetic vulnerability and those
related to illness itself. Importantly, the SZ participants in our
study were in their first episode of illness. Studying those
in early stages of illness is substantially advantageous for
identifying primary neuropathological processes proximal
to initial symptom onset; findings from such samples are
not confounded by illness chronicity and recurrence. Half
of the FE-SZ participants (24/48) were taking antipsychotic
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medications at the time of scan. Post hoc analyses indicated
no significant effects of medications on our primary WM
findings, except CC. How medications influenced CC FA
values in SZ needs further investigation in larger sample
without taking medications.
While our central findings are consistent with previous
literature, there are some differences regarding the laterality
of findings in the SLF and UF and the specific subregions
of CC that are affected in SZ [3, 40, 43, 45]. We found
abnormalities in the genu/body of the CC, whereas other
studies have reported alteration in the splenium of the CC [3,
43]. These inconsistencies may arise from the criteria used in
identifying at-risk individuals and variations and differences
in data processing procedures due to the variety of algorithms
and software tools available. Prior studies have varied in
using familial predisposition [20, 29] or the presence of
prodromal symptoms [44, 52] to determine risk status for
SZ. Other potential factors in inconsistencies among studies
include age, ethnic make-up of study samples, and acquisition
parameters of different MRI scanning systems.
Consistent with the previous studies [53, 54], FE-SZ
group demonstrated higher psychotic symptom scores, and
positive correlation between the SLF FA values and hallucinations and thought disorder. This suggests that the
SLF abnormalities may contribute to the hallucinations and
thought disorder associated with schizophrenia. Additionally, we found that both EF-SZ and GHR-SZ showed worse
WCST performance, compared to HC, which implicated that
the executive performance may be related to the genetic susceptibility to SZ; however, no correlation exists between the
WCST performance and FA values of the shared abnormal
WM between GHR-SZ and FE-SZ.

5. Limitations
Our study is limited by the use of a cross-sectional design.
Longitudinal studies are required to track the eventual
development of schizophrenia in the high-risk group to
confirm that findings are related to risk for the development
of schizophrenia rather than protective factors. Second, the
HR group in current study included only 37 individuals
who are the children of patients with SZ. The sample size
may be small considering heterogeneity in this sample, as
only a portion of these individuals will later develop SZ.
Future studies should distinguish between genetically highrisk relatives without symptoms, and those with existing
prodromal symptoms without familial risk. Third, there are
some potential problems with the voxel-based DTI analyses
that were performed in the study to explore whole brain white
matter abnormalities. For example, there is no satisfactory
solution to aligning FA images from multiple subjects [55],
and the applications of different spatial smoothing extent can
give rise to varying results [56]. Further investigation with
complementary DTI techniques, such as combining tractbased spatial statistics, would be important.

6. Conclusion
In summary, this study lends further support to the critical
involvement of WM disruptions in SZ. Importantly, shared
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and distinct alterations in WM integrity were observed
between FE-SZ and GHR-SZ. The shared abnormalities in
the CC, AC, and UF may stem from genetic vulnerability to
SZ that are present in both FE-SZ and GHR-SZ; whereas the
distinct changes in the SLF and FX seen only in the FE-SZ
group may point to separate neural mechanisms responsible
for psychotic symptoms in SZ, such as hallucinations. Future
studies may further elucidate differentiating features between
FE-SZ and GHR-SZ, which would improve prediction of
psychotic conversion in at-risk individuals. Such differentiation could significantly strengthen the effectiveness of early
identification and intervention strategies in SZ, a disorder in
which initiation of treatment at the time of psychotic onset
is often too late for substantial impact on clinical outcome in
affected individuals.
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